STOCK TITAN

[Form 4] MOELIS & COMPANY Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Kenneth Shropshire, a director of Moelis & Co (MC), reported a sale of Class A common stock on 08/22/2025. He sold 2,615 shares at a price of $72.52 per share and, following the transaction, beneficially owned 7,109 shares. The Form 4 was signed by an attorney-in-fact on 08/27/2025.

Kenneth Shropshire, direttore di Moelis & Co (MC), ha comunicato la vendita di azioni ordinarie di Classe A in data 22/08/2025. Ha venduto 2.615 azioni al prezzo di $72,52 per azione e, dopo la transazione, deteneva beneficiariamente 7.109 azioni. Il Modulo 4 è stato firmato da un procuratore il 27/08/2025.

Kenneth Shropshire, director de Moelis & Co (MC), informó la venta de acciones ordinarias Clase A el 22/08/2025. Vendió 2.615 acciones a $72,52 por acción y, tras la operación, poseía beneficiariamente 7.109 acciones. El Formulario 4 fue firmado por un apoderado el 27/08/2025.

Kenneth Shropshire, Moelis & Co (MC) 이사, 2025-08-22에 클래스 A 보통주 매도 사실을 신고했습니다. 그는 주당 $72.522,615주를 매도했으며, 거래 후 실질적으로 보유한 주식은 7,109주였습니다. 양식 4는 2025-08-27에 대리인(법정대리인)에 의해 서명되었습니다.

Kenneth Shropshire, administrateur de Moelis & Co (MC), a déclaré la vente d'actions ordinaires de Classe A le 22/08/2025. Il a vendu 2 615 actions au prix de 72,52 $ par action et, après la transaction, détenait bénéficiairement 7 109 actions. Le formulaire 4 a été signé par un mandataire le 27/08/2025.

Kenneth Shropshire, Direktor von Moelis & Co (MC), meldete am 22.08.2025 den Verkauf von Class-A-Stammaktien. Er verkaufte 2.615 Aktien zu einem Preis von $72,52 je Aktie und hielt nach der Transaktion wirtschaftlich 7.109 Aktien. Das Formular 4 wurde am 27.08.2025 von einem Bevollmächtigten unterschrieben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Director disposed of a modest holding; transaction signals insider selling but appears limited in size.

The sale of 2,615 shares at $72.52 reduced Kenneth Shropshire's direct beneficial ownership to 7,109 shares. This Form 4 discloses a routine insider sale rather than an issuance or option exercise. There is no additional context in the filing about reasons, plans, or related derivative activity. The transaction is clearly documented and timely filed by attorney-in-fact.

TL;DR: Compliance appears appropriate; Form 4 discloses a single open-market sale by a company director.

The filing identifies Shropshire as a director and reports the sale details, meeting Section 16 reporting requirements. No amendments, plans, or related-party transfers are disclosed. From a governance and disclosure standpoint, the form provides the required information but offers no explanation for the sale.

Kenneth Shropshire, direttore di Moelis & Co (MC), ha comunicato la vendita di azioni ordinarie di Classe A in data 22/08/2025. Ha venduto 2.615 azioni al prezzo di $72,52 per azione e, dopo la transazione, deteneva beneficiariamente 7.109 azioni. Il Modulo 4 è stato firmato da un procuratore il 27/08/2025.

Kenneth Shropshire, director de Moelis & Co (MC), informó la venta de acciones ordinarias Clase A el 22/08/2025. Vendió 2.615 acciones a $72,52 por acción y, tras la operación, poseía beneficiariamente 7.109 acciones. El Formulario 4 fue firmado por un apoderado el 27/08/2025.

Kenneth Shropshire, Moelis & Co (MC) 이사, 2025-08-22에 클래스 A 보통주 매도 사실을 신고했습니다. 그는 주당 $72.522,615주를 매도했으며, 거래 후 실질적으로 보유한 주식은 7,109주였습니다. 양식 4는 2025-08-27에 대리인(법정대리인)에 의해 서명되었습니다.

Kenneth Shropshire, administrateur de Moelis & Co (MC), a déclaré la vente d'actions ordinaires de Classe A le 22/08/2025. Il a vendu 2 615 actions au prix de 72,52 $ par action et, après la transaction, détenait bénéficiairement 7 109 actions. Le formulaire 4 a été signé par un mandataire le 27/08/2025.

Kenneth Shropshire, Direktor von Moelis & Co (MC), meldete am 22.08.2025 den Verkauf von Class-A-Stammaktien. Er verkaufte 2.615 Aktien zu einem Preis von $72,52 je Aktie und hielt nach der Transaktion wirtschaftlich 7.109 Aktien. Das Formular 4 wurde am 27.08.2025 von einem Bevollmächtigten unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shropshire Kenneth

(Last) (First) (Middle)
399 PARK AVE

(Street)
NEW YORK NY 10022

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Moelis & Co [ MC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 08/22/2025 S 2,615 D $72.52 7,109 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Osamu Watanabe as attorney-in-fact for Kenneth Shropshire 08/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Kenneth Shropshire report on the Form 4 for MC?

The Form 4 reports a sale of 2,615 Class A shares at $72.52 per share on 08/22/2025.

How many shares does Kenneth Shropshire beneficially own after the reported sale?

Following the sale, Shropshire beneficially owned 7,109 shares of Moelis & Co Class A common stock.

Was the Form 4 filed timely and who signed it?

The Form 4 shows the transaction date as 08/22/2025 and was signed by Osamu Watanabe as attorney-in-fact on 08/27/2025.

Did the filing disclose any derivative transactions or trading plans (10b5-1)?

No derivative securities, trading plans, or 10b5-1 contract disclosures are included in this Form 4.

Does the Form 4 indicate whether the sale was part of a larger group filing?

The form is marked as filed by one reporting person, indicating an individual filing for Shropshire.
Moelis & Co

NYSE:MC

MC Rankings

MC Latest News

MC Latest SEC Filings

MC Stock Data

5.38B
73.38M
1.07%
103.7%
3.92%
Capital Markets
Investment Advice
Link
United States
NEW YORK